Second primary cancers in patients with cutaneous malignant melanoma: A population-based study in Sweden

British Journal of Cancer

Volumn 73, Issue 2, 1996, Pages 255-259

  Wassberg, C ^a   Thorn M ^a   Yuen, J ^a   Ringborg, U ^b   Hakulinen, T ^b,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c FINNISH CANCER REGISTRY   (Finland)

Author keywords

Melanoma; Multiple tumours; Statistics

Indexed keywords

ADULT; AGE; ARTICLE; CANCER RISK; COLON CANCER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MELANOMA; NERVOUS SYSTEM TUMOR; NEUROECTODERM TUMOR; PRIORITY JOURNAL; SECOND CANCER; SEX DIFFERENCE; SKIN CANCER; SWEDEN;

EID: 0030050694     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.45     Document Type: Article

References (34)

1. BERGMAN W, WATSON P, DE JONG J, LYNCH HT AND FUSARO RM. (1990). Systemic cancer and the FAMMM syndrome. Br. J. Cancer, 61, 932-936.
2. BOLAND SL, SHAW HM AND MILTON GW. (1976). Multiple primary cancers in patients with malignant melanoma. Med. J. Australia, 1, 517-519.
3. THE CANCER REGISTRY. (1960-91). Cancer Incidence in Sweden 1958-1988. National Board of Health and Welfare: Stockholm.
4. EVANS RD, KOPF AW, LEW RA, RIGEL DS, BART RS, FRIEDMAN RJ AND RIVERS JK. (1988). Risk factors for the development of malignant melanoma-I: Review of case-control studies. J. Dermatol. Surg. Oncol., 14, 393-408.
5. FISHER RI. (1976). Estrogen receptors in human malignant melanoma. Lancet, 2, 337-338.
6. FLETCHER WS. (1973). The incidence of other primary tumours in patients with malignant melanoma; In Mechanisms in Pigmentation. Pigment Cell, Vol 1, McGovern VJ, Russel P. (eds) pp. 255-260. Karger: Basle.
7. FRASER DG, BULL JG JR. AND DUNPHY JE. (1971). Malignant melanoma and coexisting neoplasms. Am. J. Surgery, 122, 169-174.
8. GREENE MH, HOOVER RN AND FRAUMENI JF. JR. (1978). Subsequent cancer in patients with chronic lymphocytic leukemia - A possible immunologic mechanism. J. Natl Cancer Inst., 61, 337-340.
9. GREENE MH, YOUNG TI AND CLARK WH JR. (1981). Malignant melanoma in renal transplant recipients. Lancet, 1, 1196-1198.
10. GUTMAN M, CHAAN A, INBAR M, SHAFIR R, CHAITCHIK S, ROZIN RR AND KLAUSNER MJ. (1991). Are malignant melanoma patients at higher risk for a second cancer? Cancer, 68, 660-665.
11. HERSEY P, EDWARDS A, HONEYMAN M AND MCCARTHY WH. (1979). Low natural-killer-cell activity in familial melanoma patients and their relatives. Br. J. Cancer, 40, 113-122.
12. KAMB A, GRUIS NA, WEAVER-FELDHAUS J, LIU Q, HARSHMAN K, TAVTIGIAN SV, STOCKERT E, DAY III RS, JOHNSON BE AND SKOLNICK MH. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
13. LEE JA. (1982). Melanoma and exposure to sunlight. Epidemiol. Rev., 4, 110-136.
14. LINDELÖF B, SIGURGEIRSSON B, WALLBERG P AND EKLUND G (1991). Occurrence of other malignancies in 1,973 patients with basal cell carcinoma. J. Am. Acad. Dermatol., 25, 245-248.
15. MAGNUS K. (1977). Incidence of malignant melanoma of the skin in the five Nordic countries: significance of solar radiation. Int. J. Cancer, 20, 477-485.
16. MATTSSON B AND WALLGREN A. (1984). Completeness of the Swedish Cancer Registry. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol. Oncol., 23, 305-313.
17. NOBORI T, MIURA K, WU DJ, LOIS A, TAKABAYASHI K AND CARSON DA. (1994). Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
18. ÖSTERLIND A, TUCKER MA, STONE BJ AND JENSEN OM. (1988). The Danish case-control study of cutaneous malignant melanoma II. Importance of UV-light exposure. Int. J. Cancer, 42, 319-324.
19. SCHALLREUTER KU, LEVENIG CH AND BERGER J. (1993). Cutaneous malignant melanomas with other coexisting neoplasms: a true association? Dermatology, 186, 12-17.
20. SCHOENBERG BS AND CHRISTINE BW. (1980). Malignant melanoma associated with breast cancer. South Med. J., 73, 1493-1497.
21. SLINGLUFF CL JR, REINTGEN DS, VOLLMER RT AND SEIGLER HF. (1990). Malignant melanoma arising during pregnancy. A study of 100 patients. Ann. Surg., 211, 552-557.
22. SNELL RS AND BISCHITZ PG. (1960). The effect of large doses of estrogen and progesterone on melanin pigmentation. J. Invest. Derm., 35, 73-82.
23. STATISTICS SWEDEN. (1959-91). Causes of Death. Annual Publication for 1958-1988. National Board of Health and Welfare: Stockholm.
24. STEDMAN KE, MOORE GE AND MORGAN RT. (1980). Estrogen receptor proteins in diverse human tumors. Arch. Surg., 115, 244-248.
25. TEPPO L, PUKKALA E AND SAXÉN E. (1985). Multiple cancer an epidemiologic exercise in Finland. J. Natl Cancer Inst., 75, 207-217.
26. THÖRN M, ADAMI H-O, RINGBORG U, BERGSTRÖM R AND KRUSEMO U-B. (1987). Long-term survival in malignant melanoma with special reference to age and sex as prognostic factors. J. Natl Cancer Inst., 79, 969-974.
27. THÖRN M, BERGSTRÖM R, ADAMI H-O AND RINGBORG U. (1990). Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am. J. Epidemiol., 132, 1066-1077.
28. TRAVIS LB, CURTIS RE, BOICE JD JR, HANKEY BF AND FRAUMENI JF JR. (1991). Second cancers following non-Hodgkin's lymphoma. Cancer, 67, 2002-2009.
29. TRAVIS LB, CURTIS RE, HANKEY BF AND FRAUMENI JF JR. (1992). Second cancers in patients with chronic lymphocytic leukemia. J. Natl Cancer Inst., 84, 1422-1427.
30. TRAVIS LB, CURTIS RE, GLIMELIUS B, HOLOWATY E, VAN LEEUWEN FE, LYNCH CF, ADAMI J, GOSPODAROWICZ M, WACHOLDER S, INSKIP P, TUCKER MA, FRAUMENI JF AND BOICE JD. (1993). Second cancers among long-term survivors of Non-Hodgkin's lymphoma. J. Natl Cancer Inst., 85, 1932-1937.
31. TUCKER MA, BOICE JD AND HOFFMAN PA. (1985a). Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone and eye in Connecticut, 1935-82. NCI Monograph, 68, 161-197.
32. TUCKER MA, MISFELDT D, COLEMAN CN, CLARK WH JR. AND ROSENBERG SA. (1985A). Cutaneous malignant melanoma after Hodgkin's disease. Ann. Int. Med., 102, 37-41.
33. VAN LEEUWEN FE, KLOKMAN WJ, HAGENBEEK A, NOYON R, VAN DEN BELT-DUSEBOUT AW, VAN KERKHOFF EHM, VAN HEERDE P AND SOMERS R. (1994). Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J. Clin. Oncol., 12, 312-325.
34. WORLD HEALTH ORGANIZATION. (1957). Manual of the International Statistical Classification of Diseases. Injuries, and Causes of Death, 7th revision. World Health Organization: Geneva.